Earnings · China A-shares
Harbin Medisan Pharmaceutical Co., Ltd. Class A (002900) earnings
Harbin Medisan Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-27: net profit +54.85% year on year, +48.80% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -0.61% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-27
- Period end
- 2026-09-30
- Net profit YoY
- +54.85%
- Excl. one-offs YoY
- +48.80%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +1.21% | — |
| 3 days | -0.61% | — |
| 7 days | +3.74% | — |
| 14 days | -0.30% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 1 of 6 reports (average -2.23%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-28 | -¥94.29M | +54.85% | +48.80% | +7.32% | -0.30 | -5.46% | -0.61% | — | — |
| 2026 interim report | 2026-08-27 | -¥44.19M | +52.17% | +40.40% | +3.79% | -0.14 | -2.52% | -6.53% | -15.35% | -6.41% |
| 2026 Q1 report | 2026-04-28 | -¥7.06M | +75.54% | +40.19% | +11.61% | -0.02 | -0.40% | +6.06% | -10.28% | -9.65% |
| 2025 annual report | 2026-04-28 | -¥339.63M | -678.82% | — | -30.29% | -1.07 | -17.32% | +6.06% | -10.28% | -9.65% |
| 2025 Q3 report | 2025-10-25 | -¥208.84M | -614.61% | — | -30.75% | -0.66 | -10.29% | -2.96% | -1.55% | -1.33% |
| 2025 interim report | 2025-08-27 | -¥92.39M | -451.68% | — | -21.08% | -0.29 | -4.39% | -2.86% | -8.13% | -11.91% |
| 2025 Q1 report | 2025-04-25 | -¥28.85M | -253.52% | — | -16.93% | -0.09 | -1.37% | -6.51% | +33.13% | +29.89% |
| 2024 annual report | 2025-04-25 | ¥58.68M | -20.35% | +73.85% | -4.58% | 0.19 | 2.75% | -6.51% | +33.13% | +29.89% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.